Mahmut Töbü

421 total citations
44 papers, 279 citations indexed

About

Mahmut Töbü is a scholar working on Hematology, Surgery and Oncology. According to data from OpenAlex, Mahmut Töbü has authored 44 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 9 papers in Surgery and 9 papers in Oncology. Recurrent topics in Mahmut Töbü's work include Blood Coagulation and Thrombosis Mechanisms (9 papers), Lymphoma Diagnosis and Treatment (7 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Mahmut Töbü is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (9 papers), Lymphoma Diagnosis and Treatment (7 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Mahmut Töbü collaborates with scholars based in Türkiye and United States. Mahmut Töbü's co-authors include Jawed Fareed, Omer Iqbal, Debra Hoppensteadt, Güray Saydam, Vinod Bansal, Debra A. Hoppensteadt, Harry L. Messmore, Rüçhan Uslu, Walter Jeske and Serdar Bedii Omay and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Thrombosis and Haemostasis.

In The Last Decade

Mahmut Töbü

36 papers receiving 270 citations

Peers

Mahmut Töbü
M. Palm Sweden
Harriet E. Allan United Kingdom
Jennifer Yui United States
Y. Takeda United States
Mahmut Töbü
Citations per year, relative to Mahmut Töbü Mahmut Töbü (= 1×) peers Paola Ranalli

Countries citing papers authored by Mahmut Töbü

Since Specialization
Citations

This map shows the geographic impact of Mahmut Töbü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahmut Töbü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahmut Töbü more than expected).

Fields of papers citing papers by Mahmut Töbü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahmut Töbü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahmut Töbü. The network helps show where Mahmut Töbü may publish in the future.

Co-authorship network of co-authors of Mahmut Töbü

This figure shows the co-authorship network connecting the top 25 collaborators of Mahmut Töbü. A scholar is included among the top collaborators of Mahmut Töbü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahmut Töbü. Mahmut Töbü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vural, Filiz, Mahmut Töbü, Fahri Şahin, et al.. (2024). Non-Hodgkin's Lymphoma of The Tonsil: Clinical Features, Treatment Response and Prognosis. Ege Tıp Dergisi. 63(1). 86–95.
2.
Ateş, Utku, et al.. (2024). DESENSITIZATION TO RIVAROXABAN IN A PATIENT WHO EXPERIENCED ANAPHYLACTOID SHOCK AFTER ANTICOAGULANT USE: CASE REPORT. Hematology Transfusion and Cell Therapy. 46. S54–S55.
3.
Vural, Filiz, Mahmut Töbü, Fahri Şahin, et al.. (2023). Primary Thyroid Lymphoma: Single Center Experience. 7(3). 111–118.
4.
Vural, Filiz, Fahri Şahin, Mahmut Töbü, et al.. (2023). Adult Onset Langerhans Cell Histiocytosis: Clinical Characteristics and Treatment Outcomes. PubMed. 5(2-3). 101–106.
5.
Baysal, Ebru, Dilek Sarı, Filiz Vural, et al.. (2021). The Effect of Cryotherapy on the Prevention of Oral Mucositis and on the Oral pH Value in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation. Seminars in Oncology Nursing. 37(3). 151146–151146. 4 indexed citations
7.
Uslu, Rüçhan, Mahmut Töbü, Burçak Karaca, et al.. (2017). Risk factors for poor mobilization in solid tumors: How effectively can we mobilize patients with solid tumors?. Transfusion and Apheresis Science. 56(6). 809–813.
8.
Savaş, Recep, Nazan Özsan, Fahri Şahin, et al.. (2017). The role of PET/CT in evaluation of bone marrow involvement in lymphoma patients at the initial staging. Marmara medical journal. 30(1). 1–1. 4 indexed citations
9.
Özsan, Nazan, et al.. (2016). Progressive Transformation of Germinal Centers: Single-Center Experience of 33 Turkish Patients. Clinical Lymphoma Myeloma & Leukemia. 16. S149–S151. 2 indexed citations
10.
Şahin, Fahri, Buket Kosova, Zühal Eroğlu, et al.. (2011). Factor V G1691A (Leiden) and prothrombin G20210A gene mutation status, and thrombosis in patients with chronic myeloproliferative disorders. SHILAP Revista de lepidopterología. 2011(4). 306–311. 2 indexed citations
11.
Ma, Qing, Mahmut Töbü, Walter Jeske, et al.. (2006). Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides. Thrombosis Research. 119(5). 653–661. 18 indexed citations
12.
Fareed, Jawed, D. Hoppensteadt, Susannah Cort, et al.. (2005). Enoxaparin (E) and warfarin (W) differentially regulate tissue factor (TF), tissue factor pathway inhibitor (TFPI) and thrombin activatable fibrinolytic inhibitor (TAFI) in cancer patients with thrombosis. Journal of Clinical Oncology. 23(16_suppl). 2057–2057. 1 indexed citations
13.
Iqbal, Omer, Bo Eklöf, Mahmut Töbü, & Jawed Fareed. (2003). Air Travel-Associated Venous Thromboembolism. Medical Principles and Practice. 12(2). 73–80. 6 indexed citations
14.
Töbü, Mahmut, Omer Iqbal, Qing Ma, et al.. (2003). Global Anticoagulant Effects of a Synthetic Anti-Factor Xa Inhibitor (DX-9065a): Implications for Interventional Use. Clinical and Applied Thrombosis/Hemostasis. 9(1). 1–17. 3 indexed citations
15.
Töbü, Mahmut, et al.. (2002). Effects of a Synthetic Factor Xa Inhibitor (JTV-803) on Various Laboratory Tests. Clinical and Applied Thrombosis/Hemostasis. 8(4). 325–336. 12 indexed citations
16.
Aziz, Salim, Sarfraz Ahmad, Jawed Fareed, et al.. (2002). Antithrombotic agents in the treatment of severe sepsis. Expert Opinion on Emerging Drugs. 7(1). 111–139. 1 indexed citations
17.
Aydın, Hikmet Hakan, et al.. (2000). Up-regulation of serine/threonine protein phosphatase type 2A regulatory subunits during methylprednisolone-induced differentiation of leukaemic HL-60 cells. Clinical & Laboratory Haematology. 22(5). 271–274. 9 indexed citations
18.
Uzunoğlu, Selim, Rüçhan Uslu, Mahmut Töbü, et al.. (1999). Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors. Leukemia Research. 23(5). 507–512. 24 indexed citations
19.
Ok, Ercan, Fehmi Akçiçek, Murat Tombuloğlu, et al.. (1995). Alloimmune haemolytic anaemia after renal transplantation.. PubMed. 10(3). 404–5. 4 indexed citations
20.
Tombuloğlu, Murat, et al.. (1995). Kaposi's Sarcoma in the Course of Juvenile Myelodysplastic Syndrome. Acta Oncologica. 34(2). 263–264. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026